Jump to Navigation
Home

Main menu

  • Home
  • News
  • Markets Map
  • Sentiments
  • Topics
  • Data
  • Comments
  • Images
  • Blog
  • About

Secondary menu

  • Latest News
  • Top Rated
  • Most Popular
  • Archive
  • Discussions
  • The Expert View: FirstGroup, Halfords and BTG
  • How Canadian YouTube sensation ‘Kai the Hatchet Wielding...
  • Bridge collapses in Washington state
  • What 9 Company Hedge Books Are Revealing about the...
  • Doubt Deepens Further Over Polish Shale Gas
  • US Natural Gas Exports, Slowly but Surely
  • Foreign investors still buy Indian stocks, but pace slows
  • Nikkei recovers as investors pile back in
  • Bridge collapses in Washington sending cars, people...
  • Asian stocks steadier, Nikkei bounces back

    9 Big Pharmas With The Least Side Effects

    Mon, 09/26/2011 - 06:16 EDT - Seeking Alpha
    • ABT
    • AZN
    • Bill Maurer
    • BMY
    • GSK
    • LLY
    • MRK
    • NVS
    • PFE
    • SNY

    By Bill Maurer: We've all heard the commercials. This medicine will make your headache go away, or your stomach feel better, but it could cause you to bleed to death, lose your sight, or a number of other side effects. Luckily, the stocks of these companies should be a bit safer. They pay decent dividends and unless they have a major drug problem, aren't going to fall tremendously when the markets get upset like they did this week. I've taken a look at nine big pharmas, some based out of the US, some Europe. I'll throw some tables in and then analyze after. A number in bold means that the stock leads the group in that category. All these numbers were taken from either Yahoo Finance or each company's investor relations' pages.
    Prices MRK PFE GSK LLY SNY ABT BMY AZN NVS
    Current Price $31.05 $17.45 $40.67 $36.07 $31.90 $50.96 $30.89 $42.91 $53.73Complete Story »

    • Original article
    • Login or register to post comments
     

    Related

    • Drug Stocks Remain a Safety Calm in the Economic Storm

      Moby Waller submits: There's a core group of 10 major pharmaceutical companies publicly traded in the U.S., all of which have dividend yields over 3% and are within relative range of their 52 week highs. This group has been a market outperformer in calendar year 2011 thus far — given the economic uncertainty and global debt worries, this sector has been a good safety value play for many investors & traders. The companies:

    • Which Of The Top 8 Drug Makers Is Most Attractive To Dividend Investors

      By Arie Goren:Major drug manufacturers are generally very profitable and pay rich dividends. In this article, I tried to determine which of the eight top major drug manufacturers, traded in the U.S., is the most attractive for dividend-seeking investors.I consider that besides dividend yield, the consistency and the rate of raising dividend payments are the most important factors for dividend-seeking investors. Of course, it is also essential that a company has enough earnings growth prospects to maintain increasing dividend payments.

    • Analyzing Major Big Pharma Players Using Relative Valuation

      According to IMS Health, the global market for pharmaceuticals is expected to grow at an annual rate of 5 to 8 percent and reach $1.1 trillion by the year 2014. Unfortunately, outside of some mutual funds, I do not have any exposure to this sector in my personal account.

    • Tables & Charts for Tuesday, Jan 3rd, 2012

      International Economics ReviewUS Economic Calendar.Cara 100 Daily RSI-7 TablesFor interactive tables, go here.At least one RSI value >70:

    • Tables & Charts for Monday, Jan 2nd, 2012

      International Economics ReviewUS Economic Calendar.Cara 100 Daily RSI-7 TablesFor interactive tables, go here.At least one RSI value >70:

    • Tables & Charts for Friday, Dec 30th, 2011

      International Economics ReviewUS Economic Calendar.Cara 100 Daily RSI-7 TablesFor interactive tables, go here.At least one RSI value >70:

    • Tables & Charts for Tuesday, Dec 27th, 2011

      International Economics ReviewUS Economic Calendar.Cara 100 Daily RSI-7 TablesFor interactive tables, go here.At least one RSI value >70:

    • Tables & Charts for Monday, Dec 26th, 2011

      International Economics ReviewUS Economic Calendar.Cara 100 Daily RSI-7 TablesFor interactive tables, go here.At least one RSI value >70:

    • Tables & Charts for Friday, Dec 23rd, 2011

      International Economics ReviewUS Economic Calendar.Cara 100 Daily RSI-7 TablesFor interactive tables, go here.At least one RSI value >70:

    • Big Pharma Embraces Branded Generics

      Jason Chew submits: It seems not a day goes by without talk of an innovation crisis in the pharmaceutical industry. On, October 25, the German consultancy, Roland Berger, released an article titled “Fight of Flight” stating 65% of companies surveyed believe that the pharmaceutical industry is facing a strategic crisis. As the patent cliff nears, it appears the majority of Big Pharmas have taken to the “flight” path.

    Latest

    Despite 'Promises', Japanese Market Chaos Continues
    Despite 'Promises', Japanese Market...
    How Canadian YouTube sensation ‘Kai the Hatchet Wielding Hitchhiker’ went from hero to inmate
    How Canadian YouTube sensation ‘Kai the Hatchet...

    User login

    • Create new account
    • Request new password
    • Click on the icon to sign in with your social network login or enter your Bullfax.com login

    Our Blog

    • Pandora: the charm might fade away
    • Japanese Market, Indian Rupee, China’s Stocks and Oil Prices in Our Daily Round-Up for 05/23/2013
    • IMF calls on Osborne to spend on infrastructure

    Markets Map

    Markets Map

    Follow Us

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS
    S&P 500: 1650.51 -0.29% FTSE: 6696.79 -2.14% Nikk.: 14226.94 -1.81% DAX: 8351.98 -2.14% HSI: 22624.211 -0.2% FX: EUR/GBP: 1.168 USD/EUR: 1.2925 JPY/USD: 101.325 Commodities: Gold: 1395.95

    Bullfax.com - Market News & Analysis 2008-2011
    Contact Us | About Us | Terms & Conditions

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS .

    Secondary menu

    • Latest News
    • Top Rated
    • Most Popular
    • Archive
    • Discussions